The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Open accessAbstract
The administration of drugs to the central nervous system (CNS) is primarily controlled by the blood-brain barrier (BBB), a structure that prevents the passage of foreign compounds from the blood to the brain's extracellular fluid. Although currently available treatments for brain diseases that affect millions of people globally are partially effective, they are associated with severe side effects of systemic drug distribution. On the other hand, the ability of certain drugs to permeate through the BBB is impeded by their physicochemical properties, achieving sub-therapeutic concentrations in their target tissues. In this sense, the intranasal route with its unique anatomical features provides a promising passage for the delivery of drugs to the brain. Nanoparticle-based systems, in particular, have demonstrated an outstanding capacity to overcome the challenges presented by the intranasal route and produce drug accumulation in the brain while avoiding systemic distribution. This review covers recent developments in the use of polymer, lipid, and inorganic nanoparticles, as well as drug nanocrystals, to deliver drugs to the brain via intranasal administration. A general discussion including favourable aspects and limitations of this approach is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Fahmy, U. A., Ahmed, O. A. A., Badr-Eldin, S. M., Aldawsari, H. M., Okbazghi, S. Z., Awan, Z. A., Bakhrebah, M. A., Alomary, M. N., Abdulaal, W. H., Medina, C., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s258791 · Cited by 50
RetractedGadhave, D. G., Tagalpallewar, A. A., & Kokare, C. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1213-y · Cited by 49
RetractedThe blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Cell-Penetrating Peptides: Design, Synthesis, and Applications
Copolovici, D. M., Langel, K., Eriste, E., & Langel, Ü. (2014) · ACS Nano · doi:10.1021/nn4057269 · Cited by 963
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Management of common adverse effects of antipsychotic medications
Stroup, T. S., & Gray, N. (2018) · World Psychiatry · doi:10.1002/wps.20567 · Cited by 572
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Vallet-Regí, M., Colilla, M., Izquierdo-Barba, I., & Manzano, M. (2017) · Molecules · doi:10.3390/molecules23010047 · Cited by 538
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Progress in brain targeting drug delivery system by nasal route
Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402
Hanley, C., Thurber, A., Hanna, C., Punnoose, A., Zhang, J., & Wingett, D. G. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9413-8 · Cited by 374
Targeting the transferrin receptor for brain drug delivery
Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 370
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
Meng, Q., Wang, A., Hua, H., Jiang, Y., Wang, Y., Mu, H., Wu, Z., & Sun, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151474 · Cited by 310
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
Costa, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 303
How toxic are gold nanoparticles? The state-of-the-art
Fratoddi, I., Venditti, I., Cametti, C., & Russo, M. V. (2015) · Nano Research · doi:10.1007/s12274-014-0697-3 · Cited by 302
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 298
Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
Gizurarson, S. (2012) · Current Drug Delivery · doi:10.2174/156720112803529828 · Cited by 263
Sukumar, U. K., Bose, R. J. C., Malhotra, M., Babikir, H. A., Afjei, R., Robinson, E., Zeng, Y., Chang, E., Habte, F., Sinclair, R., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119342 · Cited by 251
Wen, Z., Yan, Z., Hu, K., Pang, Z., Cheng, X., Guo, L., Zhang, Q., Jiang, X., Fang, L., & Lai, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.022 · Cited by 241
Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., & Seta, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.036 · Cited by 241
Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?
Hoseini-Ghahfarokhi, M., Mirkiani, S., Mozaffari, N., Abdolahi Sadatlu, M. A., Ghasemi, A., Abbaspour, S., Akbarian, M., Farjadain, F., & Karimi, M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s265876 · Cited by 239
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
Cornelio, D. B., Roesler, R., & Schwartsmann, G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm058 · Cited by 234
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Patel, R. J., Ajazuddin, Ravichandiran, V., Murty, U. S., & Alexander, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.020 · Cited by 230
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228
Liu, Z., Jiang, M., Kang, T., Miao, D., Gu, G., Song, Q., Yao, L., Hu, Q., Tu, Y., Pang, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.003 · Cited by 217
Selvaraj, K., Gowthamarajan, K., & Karri, V. V. S. R. (2017) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2017.1420073 · Cited by 210
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C., Moreira, J. N., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 210
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 209
Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
Battaglia, L., Panciani, P. P., Muntoni, E., Capucchio, M. T., Biasibetti, E., De Bonis, P., Mioletti, S., Fontanella, M., & Swaminathan, S. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1429401 · Cited by 204
Bi, C., Wang, A., Chu, Y., Liu, S., Mu, H., Liu, W., Wu, Z., Sun, K., & Li, Y. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s120939 · Cited by 203
Permana, A. D., Paredes, A. J., Volpe-Zanutto, F., Anjani, Q. K., Utomo, E., & Donnelly, R. F. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.025 · Cited by 191
Self-citationCentral nervous system toxicity of metallic nanoparticles
Wei, L., shao, L., Feng, X., Chen, A., Zhang, Y., & Wang, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s78308 · Cited by 184
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 184
Afifi, M., Almaghrabi, O. A., & Kadasa, N. M. (2015) · BioMed Research International · doi:10.1155/2015/153573 · Cited by 182
Keck, C. M., & Müller, R. H. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.001 · Cited by 178
Nose-to-brain peptide delivery – The potential of nanotechnology
Samaridou, E., & Alonso, M. J. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 178
Gupta, S., Kesarla, R., Chotai, N., Misra, A., & Omri, A. (2017) · BioMed Research International · doi:10.1155/2017/5984014 · Cited by 172
Bhattamisra, S. K., Shak, A. T., Xi, L. W., Safian, N. H., Choudhury, H., Lim, W. M., Shahzad, N., Alhakamy, N. A., Anwer, M. K., Radhakrishnan, A. K., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119148 · Cited by 171
Nanotechnology-based drug delivery for central nervous system disorders
Nguyen, T. T., Dung Nguyen, T. T., Vo, T. K., Tran, N.-M.-A., Nguyen, M. K., Van Vo, T., & Van Vo, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112117 · Cited by 171
Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes
McGuckin, M. B., Wang, J., Ghanma, R., Qin, N., Palma, S. D., Donnelly, R. F., & Paredes, A. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.012 · Cited by 168
Self-citationKanazawa, T., Taki, H., Tanaka, K., Takashima, Y., & Okada, H. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0440-7 · Cited by 166
Cunha, S., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s305851 · Cited by 166
Youssef, N. A. H. A., Kassem, A. A., Farid, R. M., Ismail, F. A., EL-Massik, M. A. E., & Boraie, N. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.014 · Cited by 163
A study of rivastigmine liposomes for delivery into the brain through intranasal route
Arumugam, K., Subramanian, G., Mallayasamy, S., Averineni, R., Reddy, M., & Udupa, N. (2008) · Acta Pharmaceutica · doi:10.2478/v10007-008-0014-3 · Cited by 162
Hao, J., Zhao, J., Zhang, S., Tong, T., Zhuang, Q., Jin, K., Chen, W., & Tang, H. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.08.011 · Cited by 160
Chatzitaki, A., Jesus, S., Karavasili, C., Andreadis, D., Fatouros, D. G., & Borges, O. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119776 · Cited by 148
Piazzini, V., Landucci, E., D’Ambrosio, M., Fasiolo, L. T., Cinci, L., Colombo, G., Pellegrini-Giampietro, D. E., Bilia, A. R., Luceri, C., & Bergonzi, M. C. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.005 · Cited by 147
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
Bruinsmann, F. A., Pigana, S., Aguirre, T. A. S., Souto, G. D., Pereira, G. G., Bianchera, A., Fasiolo, L. T., Colombo, G., Marques, M. D. S., Pohlmann, A. R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020086 · Cited by 143
Kanazawa, T., Morisaki, K., Suzuki, S., & Takashima, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400644e · Cited by 141
Lipid Nanoparticles for Nasal/Intranasal Drug Delivery
Cunha, S., Amaral, M. H., Lobo, J. M. S., & Silva, A. C. (2017) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2017018693 · Cited by 138
Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus
Xu, Q., Boylan, N. J., Cai, S., Miao, B., Patel, H., & Hanes, J. S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.035 · Cited by 134
Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs
Clementino, A., Pellegrini, G., Banella, S., Colombo, G., Cantú, L., Sonvico, F., & Favero, E. D. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00366 · Cited by 133
Gold nanostructures: synthesis, properties, and neurological applications
Zare, I., Yaraki, M. T., Speranza, G., Najafabadi, A. H., Shourangiz-Haghighi, A., Nik, A. B., Manshian, B. B., Saraiva, C., Soenen, S. J., Kogan, M. J., et al. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01111a · Cited by 133
Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles
Sharma, D., Sharma, R. K., Sharma, N., Gabrani, R., Sharma, S. K., Ali, J., & Dang, S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0294-0 · Cited by 127
The in vivo fate of nanocrystals
Lü, Y., Qi, J., Dong, X., Zhao, W., & Wu, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.003 · Cited by 127
Patil, R. P., Pawara, D. D., Gudewar, C. S., & Tekade, A. R. (2018) · Journal of Liposome Research · doi:10.1080/08982104.2018.1552703 · Cited by 124
Akel, H., Ismail, R., & Csóka, I. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.12.014 · Cited by 123
Gadhave, D. G., & Kokare, C. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1576724 · Cited by 120
Nose-to-brain transport of aerosolised quantum dots following acute exposure
Hopkins, L. E., Patchin, E. S., Chiu, P., Brandenberger, C., Smiley‐Jewell, S. M., & Pinkerton, K. E. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.842267 · Cited by 119
Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery
Lungare, S., Hallam, K., & Badhan, R. K. S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.042 · Cited by 119
Su, Y., Sun, B., Gao, X., Dong, X., Fu, L., Zhang, Y., Li, Z., Wang, Y., Jiang, H., & Han, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01165 · Cited by 119
Fan, Y., Chen, M., Zhang, J., Maincent, P., Xia, X., & Wu, W. (2018) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2018024697 · Cited by 115
Piazza, J. E., Hoare, T. R., Molinaro, L., Terpstra, K. J., Bhandari, J., Selvaganapathy, P. R., Gupta, B. P., & Mishra, R. K. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.007 · Cited by 113
Strategies for Intranasal Delivery of Therapeutics for the Prevention and Treatment of NeuroAIDS
Hanson, L. R., & Frey, W. H. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9039-x · Cited by 112
Kanazawa, T., Taki, H., & Okada, H. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.05.001 · Cited by 112
Jojo, G. M., Kuppusamy, G., De, A., & Karri, V. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1593439 · Cited by 111
Chen, J., Zhang, C., Liu, Q., Shao, X., Feng, C., Shen, Y., Zhang, Q., & Jiang, X. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.622396 · Cited by 103
Ye, D., Zhang, X., Yue, Y., Raliya, R., Biswas, P., Taylor, S. J., Tai, Y., Rubin, J. B., Liu, Y., & Chen, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.020 · Cited by 102
Mignani, S. M., Shi, X., Karpus, A. O., & Majoral, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112905 · Cited by 99
Gadhave, D., Rasal, N., Sonawane, R., Sekar, M., & Kokare, C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.047 · Cited by 97
Transferrin-functionalized lipid nanoparticles for curcumin brain delivery
Neves, A. R., van der Putten, L., Queiroz, J. F., Pinheiro, M., & Reis, S. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.03.010 · Cited by 97
UEA I-bearing nanoparticles for brain delivery following intranasal administration
Gao, X., Chen, J., Tao, W.-Q., ZHU, J., Zhang, Q., CHEN, H., & JIANG, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.039 · Cited by 96
de Oliveira, E. R., Truzzi, E., Ferraro, L., Fogagnolo, M., Pavan, B., Beggiato, S., Rustichelli, C., Maretti, E., Lima, E. M., Leo, E., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.033 · Cited by 96
Microarray patches: Poking a hole in the challenges faced when delivering poorly soluble drugs
Paredes, A. J., McKenna, P. E., Ramöller, I. K., Naser, Y. A., Volpe‐Zanutto, F., Li, M., Abbate, M. T. A., Zhao, L., Zhang, C., Abu‐Ershaid, J. M., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202005792 · Cited by 88
Self-citationSalem, L. H., El-Feky, G. S., Fahmy, R. H., El-Gazayerly, O. N., & Abdelbary, A. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.04.007 · Cited by 87
Rompicherla, S. K. L., Arumugam, K., Bojja, S. L., Kumar, N., & Rao, C. M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02096-0 · Cited by 86
Nanoneurotherapeutics approach intended for direct nose to brain delivery
Md, S., Mustafa, G., Baboota, S., & Ali, J. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1052081 · Cited by 85
Aparicio-Blanco, J., Sebastián, V., Benoît, J., & Torres‐Suárez, A. I. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.020 · Cited by 85
Zhang, K., Lv, Li, Feng, Li, Liu, Li, & Li (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s45031 · Cited by 80
Metal Nanoparticles as Targeted Carriers Circumventing the Blood–Brain Barrier
Sintov, A. C., Velasco-Aguirre, C., Toledo, E. G., Araya, E., & Kogan, M. J. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.007 · Cited by 80
Hady, M. A., Sayed, O. M., & Akl, M. A. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111076 · Cited by 75
Dynamic Inversion Enables External Magnets To Concentrate Ferromagnetic Rods to a Central Target
Nacev, A., Weinberg, I. N., Stepanov, P. Y., Kupfer, S., Mair, L. O., Urdaneta, M. G., Shimoji, M., Fricke, S. T., & Shapiro, B. (2015) · Nano Letters · doi:10.1021/nl503654t · Cited by 74
Stimuli-Responsive Plasmonic Assemblies and Their Biomedical Applications
Fu, Q., Li, Z., Fu, F., Chen, X. S., Song, J., & Yang, H. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101014 · Cited by 73
Nose-to-Brain Delivery: Evaluation of Polymeric Nanoparticles on Olfactory Ensheathing Cells Uptake
Musumeci, T., Pellitteri, R., Spatuzza, M., & Puglisi, G. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23836 · Cited by 72
Nasr, M., & Wahdan, S. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.014 · Cited by 72
Intranasal delivery of paeoniflorin nanocrystals for brain targeting
Wu, C., Li, B., Zhang, Y., Chen, T., Chen, C., Jiang, W., Wang, Q., & Chen, T. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.11.002 · Cited by 72
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 72
Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery
Porfiryeva, N. N., Семина, И. И., Анясович, С. И., Moustafine, R. I., & Khutoryanskiy, V. V. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102432 · Cited by 71
Permana, A. D., Paredes, A. J., Volpe‐Zanutto, F., Amir, M. N., Ismail, I., Bahar, M. A., Sumarheni, Palma, S. D., & Donnelly, R. F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11179 · Cited by 71
Self-citationParedes, A. J., Ramöller, I. K., McKenna, P. E., Abbate, M. T. A., Volpe‐Zanutto, F., Vora, L. K., Kilbourne‐Brook, M., Jarrahian, C., Moffatt, K., Zhang, C., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.002 · Cited by 70
Self-citationKanazawa, T., Kaneko, M., Niide, T., Akiyama, F., Kakizaki, S., Ibaraki, H., Shiraishi, S., Takashima, Y., Suzuki, T., & Seta, Y. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.077 · Cited by 69
Masjedi, M., Azadi, A., Heidari, R., & Mohammadi‐Samani, S. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13316 · Cited by 69
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
Chen, Y., Liu, Y., Xie, J., Zheng, Q., Yue, P., Chen, L., Hu, P., & Yang, M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s265659 · Cited by 69
Sun, Y., Li, L., Xie, H., Wang, Y., Gao, S., Zhang, L., Bo, F., Yang, S., & Feng, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s247935 · Cited by 66
PEG Nanocages as Non-sheddable Stabilizers for Drug Nanocrystals
Fuhrmann, K., Schulz, J. D., Gauthier, M. A., & Leroux, J. (2012) · ACS Nano · doi:10.1021/nn2046554 · Cited by 65
Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats
Pailla, S. R., Talluri, S., Rangaraj, N., Ramavath, R., Challa, V. S., Doijad, N. S., & Sampathi, S. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00281-4 · Cited by 65
Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer’s Disease
Oyarzún, M. P., Tapia-Arellano, A., Cabrera, P., Jara-Guajardo, P., & Kogan, M. J. (2021) · Sensors · doi:10.3390/s21062067 · Cited by 65
Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches
Paredes, A. J., Volpe‐Zanutto, F., Vora, L. K., Tekko, I. A., Permana, A. D., Picco, C. J., McCarthy, H. O., & Donnelly, R. F. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100217 · Cited by 64
Self-citationinPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice
Rinaldi, F., Seguella, L., Gigli, S., Hanieh, P. N., Favero, E. D., Cantú, L., Pesce, M., Sarnelli, G., Marianecci, C., Esposito, G., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.007 · Cited by 63
Intranasal delivery of antipsychotic drugs
Katare, Y. K., Piazza, J. E., Bhandari, J., Daya, R. P., Akilan, K., Simpson, M. J., Hoare, T. R., & Mishra, R. K. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.027 · Cited by 62
The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs
Górska, A. M., & Eugenín, E. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00261 · Cited by 61
Shen, B., Shen, C., Zhu, W., & Yuan, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.015 · Cited by 59
Du, W., Li, H., Tian, B., Sai, S., Gao, Y., Lan, T., Meng, Y., & Ding, C. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110446 · Cited by 57
Abourehab, M. A. S., Khames, A., Genedy, S., Mostafa, S., Khaleel, M. A., Omar, M. M., & Sisi, A. M. E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040581 · Cited by 57
Kanazawa, T., Kurano, T., Ibaraki, H., Takashima, Y., Suzuki, T., & Seta, Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090478 · Cited by 56
Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review
Ansari, M. A., Chung, I., Rajakumar, G., Alzohairy, M. A., Alomary, M. N., Thiruvengadam, M., Pottoo, F. H., & Ahmad, N. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200116153912 · Cited by 55
Pang, L., Zhu, S., Ma, J., Zhu, L., Liu, Y., Ou, G., Li, R., Wang, Y., Liang, Y., Jin, X., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.014 · Cited by 55
Polymeric nanocapsules with up-converting nanocrystals cargo make ideal fluorescent bioprobes
Bazylińska, U., Wawrzyńczyk, D., Kulbacka, J., Frąckowiak, R., Cichy, B., Bednarkiewicz, A., Samoc, M. J., & Wilk, K. A. (2016) · Scientific Reports · doi:10.1038/srep29746 · Cited by 51
Patel, H., Chaudhari, P. S., Gandhi, P. A., Desai, B. V., Desai, D. T., Dedhiya, P. P., Vyas, B., & Maulvi, F. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120474 · Cited by 51
Extrapyramidal Symptoms Are Serious Side-effects of Antipsychotic and Other Drugs
BLAIR, D. T., & Dauner, A. (1992) · The Nurse Practitioner · doi:10.1097/00006205-199211000-00018 · Cited by 50
Hosny, K. M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s261855 · Cited by 46
Toledo, E. G., Tapia-Arellano, A., Célis, F., Sinai, T., Campos, M., Kogan, M. J., & Sintov, A. C. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119957 · Cited by 46
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington’s Disease
Passoni, A., Favagrossa, M., Colombo, L., Bagnati, R., Gobbi, M., Diomede, L., Birolini, G., Paolo, E. D., Valenza, M., Cattaneo, E. F., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00581 · Cited by 44
Schlachet, I., & Sosnik, A. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04766 · Cited by 41
Formulation of Polymeric Nanoparticles of Antidepressant Drug for Intranasal Delivery
Jani, P., Vanza, J. D., Pandya, N., & Tandel, H. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0060 · Cited by 41
Pohlmann, A. R., Mezzalira, G., Venturini, C. D. G., Cruz, L., Bernardi, A., Jäger, E., Battastini, A. M. O., da Silveira, N. P., & Guterres, S. S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.007 · Cited by 40
Magnetic drilling enhances intra-nasal transport of particles into rodent brain
Jafari, S., Mair, L. O., Weinberg, I. N., Baker-McKee, J., Hale, O., Watson-Daniels, J., English, B. W., Stepanov, P. Y., Ropp, C., Atoyebi, O. F., et al. (2018) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2018.08.048 · Cited by 40
Yang, X., Chen, X., Lei, T., Qin, L., Zhou, Y., Hu, C., Liu, Q., & Gao, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.011 · Cited by 40
Scalable Manufacturing Processes for Solid Lipid Nanoparticles
Anderluzzi, G., Lou, G., Su, Y., & Perrie, Y. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190925112942 · Cited by 39
Nose-to-Brain Translocation and Cerebral Biodegradation of Thin Graphene Oxide Nanosheets
Newman, L., Rodrigues, A. F., Jasim, D. A., Vacchi, I. A., Ménard‐Moyon, C., Bianco, A., Bussy, C., & Kostarelos, K. (2020) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2020.100176 · Cited by 36
Shrestha, N., Khan, S., Neupane, Y. R., Dang, S., Md, S., Fahmy, U. A., Kotta, S., Alhakamy, N. A., Baboota, S., & Ali, J. (2020) · Polymers · doi:10.3390/polym12112589 · Cited by 33
Zada, M. H., Kubek, M. J., Khan, W., Kumar, A., & Domb, A. J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.050 · Cited by 31
Gupta, S. K., Kesarla, R., & Omri, A. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583206 · Cited by 31
Taymouri, S., Minaiyan, M., Ebrahimi, F., & Tavakoli, N. (2019) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2019.0156 · Cited by 26
Nose to Brain Delivery of Midazolam Loaded PLGA Nanoparticles: In Vitro and In Vivo Investigations
Sharma, D., Sharma, R. K., Bhatnagar, A., Nishad, D. K., Singh, T., Gabrani, R., Sharma, S. K., Ali, J., & Dang, S. (2016) · Current Drug Delivery · doi:10.2174/1567201812666150507120124 · Cited by 25
Kulkarni, S. D., Ramaswamy, B., Horton, E. L., Gangapuram, S., Nacev, A., Depireux, D. A., Shimoji, M., & Shapiro, B. (2015) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2015.05.069 · Cited by 25
Sun, Y., Du, L., Yang, M., Li, Q., Jia, X., Li, Q., Zhu, L., Zhang, Y., Liu, Y., & Liu, S. (2021) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2021.07.003 · Cited by 24
A new nanovesicular system for nasal drug administration
Touítou, E., Duchi, S., & Natsheh, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119243 · Cited by 23
Qian, S., Wang, Q., & Zuo, Z. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.956080 · Cited by 18
Vinaud, M. C., Real, D. A., Fraga, C. M., de Lima, N. F., Lino, R. D. S., Leonardi, D., & Salomon, C. J. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0017 · Cited by 15
Self-citation
Cited by
Koo, J., Lim, C., & Oh, K. T. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s439181 · Cited by 174
Kumar, S., Yadav, A., Verma, R. K., Kumar, A., Gupta, P. K., & Shukla, R. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00386 · Cited by 14
Metadata
- Authors
- Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J.
- Venue
- Applied Materials Today
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 29
- Pages
- 101631
- ISSN
- 2352-9407 (ISSN-L)
- OpenAlex
- W4294597228
- Cited by
- 282
- References
- 138
- FWCI
- 19.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.